Last reviewed: May 29, 2026

Last updated: May 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

NAD+ (nicotinamide adenine dinucleotide) is obtained through precursor supplementation—primarily nicotinamide riboside (NR), NMN, or direct NAD+ products—rather than as a standalone pharmaceutical. Bioavailability varies significantly by formulation, with NR showing 30-50% oral absorption and NMN demonstrating 10-20% in animal models.

Accessing NAD+ therapy safely requires understanding administration routes, stability considerations, and whether your metabolic profile warrants supplementation. PlexusDx's biomarker-driven philosophy applies here: not all aging or metabolic concerns respond equally to NAD+ support, making baseline assessment and provider guidance essential before starting any protocol.

NAD+ Supplementation Routes: Oral, IV, and Precursor Forms

NAD+ is available through multiple administration pathways. Oral precursors (nicotinamide riboside, NMN) are accessible without prescription at varying quality levels. IV NAD+ administration, offered through specialized clinics, bypasses first-pass metabolism but requires medical supervision and is not covered by insurance.

Each route has distinct absorption kinetics and cost profiles. Oral forms range $40–$200/month; IV protocols typically cost $300–$1,200 per session. Provider consultation helps determine which route aligns with your metabolic status, budget, and therapeutic goals.

Dosing, Timing, and Storage Protocols for NAD+ Products

Standard oral NAD+ precursor dosing ranges 250–1,000 mg daily, divided into 2–3 doses. NR and NMN are typically taken with food to optimize absorption. IV protocols range 500–5,000 mg per infusion, administered weekly to monthly depending on provider protocol and clinical indication.

Storage is critical: NAD+ precursors degrade in heat and humidity. Keep oral products in cool, dry conditions (under 77°F); IV solutions must be refrigerated and used within specific timeframes. Always check expiration dates and source integrity.

NAD+ Form Typical Dose Frequency Storage Requirement
Nicotinamide Riboside (NR) 250–500 mg Once or twice daily Room temp, dry, <77°F
NMN (Nicotinamide Mononucleotide) 250–1,000 mg Once daily or divided Cool, dry storage; consider refrigeration
IV NAD+ Drip 500–5,000 mg Weekly to monthly Refrigerated; 24–72 hr stability post-prep
Sublingual NAD+ Tablets 100–300 mg 1–3 times daily Sealed container, away from light and moisture

Evaluating NAD+ Efficacy: Biomarkers and Clinical Endpoints

NAD+ response is best tracked through functional biomarkers rather than serum NAD+ levels alone. Key metrics include mitochondrial function markers (lactate, phosphate ratios during exercise), NAD+-dependent enzyme activity (sirtuins, PARPs), and age-related phenotypes like grip strength and cognitive performance.

Provider-supervised assessments typically occur at 6, 12, and 24 weeks. Studies on NAD+ supplementation show modest improvements in energy, endurance, and age-related markers in some populations, but response is highly variable. Baseline mitochondrial capacity, age, and metabolic status influence outcomes significantly.

Who Should Use NAD+ and When Provider Oversight Is Non-Negotiable

NAD+ supplementation may be appropriate for adults over 40 with documented metabolic decline, mitochondrial dysfunction, or chronic fatigue—but only after provider assessment. Contraindications include pregnancy, active cancer treatment, severe liver or kidney disease, and certain genetic variants affecting NAD+ metabolism (NAMPT polymorphisms, PARP overactivity disorders).

Before starting any NAD+ protocol, work with a provider to assess baseline NAD+ status (via functional testing, not just serum levels), confirm no drug interactions, and establish measurable endpoints. Regular follow-up ensures safety and helps determine whether continued supplementation is warranted based on your individual response.

How PlexusDx Supports a More Personalized Approach

NAD+ metabolism intersects with peptide pathways in aging and metabolic health. PlexusDx's Precision Peptide Genetic Test identifies variants in key longevity genes—including SIRT genes (sirtuins, which are NAD+-dependent) and metabolic regulators—that may provide context for whether NAD+ supplementation aligns with your genetic predispositions. These insights should be interpreted with a qualified healthcare provider.

Your genetic profile in NAD+-dependent pathways (such as sirtuin signaling and mitochondrial biogenesis genes) may help inform whether NAD+ is a suitable complement to your broader metabolic strategy. The test does not predict exact NAD+ response or outcomes, but can support a more nuanced conversation with your provider about whether supplementation fits your biochemical foundation.

If you're considering NAD+ therapy alongside metabolic optimization strategies like GLP-1 support or other lifestyle interventions, a provider-guided biomarker assessment—including genetic predisposition screening—ensures all components work synergistically. PlexusDx can help you understand your peptide pathway genetics, which informs whether complementary longevity therapies like NAD+ are a good fit.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I buy NAD+ directly without a prescription?

Yes. Oral NAD+ precursors (NR, NMN) are available over-the-counter from supplement retailers. IV NAD+ requires provider administration at specialized clinics. Quality varies widely; source from reputable, third-party-tested vendors.

What does clinical evidence say about NAD+ for energy and aging?

Human trials show modest improvements in aerobic capacity, muscle endurance, and some age-related markers. Effects vary significantly by age, baseline mitochondrial health, and dose. Evidence is strongest in older adults (65+) and those with documented metabolic decline.

How does PlexusDx's genetic test relate to NAD+ supplementation?

The Precision Peptide Genetic Test reveals variants in sirtuin and mitochondrial genes that may provide context for NAD+-dependent pathway function. This can help your provider determine whether NAD+ supplementation aligns with your genetic predispositions.

Are there safety concerns or side effects with NAD+ supplementation?

Mild side effects include nausea, headache, and flushing. IV NAD+ occasionally causes vein irritation. Avoid if pregnant, undergoing cancer treatment, or have severe liver/kidney disease. Always consult your provider before starting.

How do I know if NAD+ is working for me?

Track functional improvements: energy levels, endurance, cognitive clarity, sleep quality. Work with your provider to measure biomarkers (lactate clearance, sirtuin activity, mitochondrial function) at 6–12 weeks. Response timelines vary widely.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves